December 7, 2007 – The Siemens “Win an MRI" contest has closed and the polls are now open to award a MAGNETOM Essenza ...
December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard Inc. for up to $140 million. The transaction is expected to close in January 2008, pending regulatory approvals.
December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was ...
By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - More so than in previous years ...
December 6, 2007 - Boston Scientific Corp. welcomed the recommendation of a FDA advisory panel to approve with ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - At this year’s RSNA more PACS ...
December 6, 2007 – Patients treated with a rotablator drill less risk of perforation than those treated with the excimer ...
December 5, 2007 - Bristol-Myers Squibb will divest its medical imaging division as part of an initiative to maximize ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Starion Instruments' TLS3 Tissue Ligating Shears feature Starion’s proprietary thermal welding technology, focusing ...
December 5, 2007 - The United Kingdom's Department of Health said today it will begin a new stroke strategy in which ...
December 4, 2007 - In general, drug-eluting stents (DES) achieve better results than bare-metal stents do, U.S ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 4, 2007 – The Impella 2.5, a catheter-based heart pump device, supports high-risk patient’s weakened heart in ...
December 4, 2007 - Patients treated with Abbott Laboratories Inc.’s experimental drug-coated heart stent had low rates ...
December 4, 2007 - ELA Medical Inc. intiated U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications), which will evaluate therapies and advanced algorithms in optimizing treatment and managing ICD patients.
December 06, 2007
